Page last updated: 2024-11-07

2-acetylaminofluorene and Schistosomiasis

2-acetylaminofluorene has been researched along with Schistosomiasis in 1 studies

2-Acetylaminofluorene: A hepatic carcinogen whose mechanism of activation involves N-hydroxylation to the aryl hydroxamic acid followed by enzymatic sulfonation to sulfoxyfluorenylacetamide. It is used to study the carcinogenicity and mutagenicity of aromatic amines.

Schistosomiasis: Infection with flukes (trematodes) of the genus SCHISTOSOMA. Three species produce the most frequent clinical diseases: SCHISTOSOMA HAEMATOBIUM (endemic in Africa and the Middle East), SCHISTOSOMA MANSONI (in Egypt, northern and southern Africa, some West Indies islands, northern 2/3 of South America), and SCHISTOSOMA JAPONICUM (in Japan, China, the Philippines, Celebes, Thailand, Laos). S. mansoni is often seen in Puerto Ricans living in the United States.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Siwela, AH1
Nyathi, CB1
Chetsanga, CJ1
Hasler, JA1

Other Studies

1 other study available for 2-acetylaminofluorene and Schistosomiasis

ArticleYear
The effect of schistosomiasis on the covalent binding of 2-acetylaminofluorene to mouse liver macromolecules in vivo and in vitro.
    Biochemical pharmacology, 1990, Jul-15, Volume: 40, Issue:2

    Topics: 2-Acetylaminofluorene; Animals; DNA; In Vitro Techniques; Liver; Mice; Mice, Inbred BALB C; Protein

1990